To evaluate the frequency of damaging/possibly pathogenic variants in NPL, POLN, RASAL1 and ROS1 in familial BC, we used a target panel covering all exons and exon-intron boundaries for these genes (custom-made TruSeq amplicon kit, designed with the DesignStudio software [23]). The gene discussed is NPL; the disease is breast cancer.